Payzin, Kadriye Bahriye <br/><br/>
JAK2 V617F mutation status of 232 patients diagnosed with chronic myeloproliferative neoplasms.  [electronic resource] 

 -  Clinical lymphoma, myeloma & leukemia  Dec 2014 
 - 525-33 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2152-2669 
<br/><br/><label>Standard No.: </label>10.1016/j.clml.2014.02.013  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Alleles<br/>Chronic Disease<br/>Codon<br/>Disease Progression<br/>Female<br/>Follow-Up Studies<br/>Genotype<br/>Humans<br/>Janus Kinase 2--genetics<br/>Male<br/>Middle Aged<br/>Mutation<br/>Myeloproliferative Disorders--complications<br/>Phenotype<br/>Thrombosis--etiology<br/>Treatment Outcome<br/>Young Adult